The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Neuropathy severity at the time of oxaliplatin treatment alteration in patients with colon cancer (Alliance A151912).

Daniel Louis  Hertz

Research Funding - Disarm Therapeutics

(OPTIONAL) Uncompensated Relationships - PEPID; Saladax Biomedical

Travis  Dockter

No Relationships to Disclose

Daniel V.  Satele

No Relationships to Disclose

Charles L.  Loprinzi

Consulting or Advisory Role - Asahi Kasei; Disarm Therapeutics; Metys Pharmaceuticals; Mitsubishi Tanabe Pharma; NKMax; OnQuality Pharmaceuticals; PledPharma

Research Funding - Bristol-Myers Squibb (Inst)

Other Relationship - Cynosure/Hologic

Jennifer  Le-Rademacher

No Relationships to Disclose